News Archive

The Biotechnology Innovation Organization (BIO), the National Science Foundation (NSF) and the National Institutes of Health (NIH) today announced an agreement to feature Small Business Innovation Research (SBIR)-funded early-stage biomedical companies in an Innovation Zone at the 2017 BIO International Convention. The Innovation Zone companies, focused on drug discovery, diagnostics and other therapeutic platform technologies, will have dedicated exhibit space and participate in BIO’s One-on-One Partnering™ system. Select companies will make 15-minute company presentations in the BIO Business Forum.

ByteGrid Holdings LLC, which is dedicated to providing the most secure and compliant hosting solutions available, has been awarded “FedRAMP Ready” status by the Federal Risk and Authorization Management Program (FedRAMP).

“We are pleased to announce this achievement as we continue to add to our capability in delivering a highly secure and regulatory compliant set of products and services to our customers. This is just one more example of ByteGrid’s commitment to serving our customers’ requirements and going the extra mile in protecting their systems and data,” said Michael Duckett, Bytegrid CEO.

This isn’t Brian Loew’s first run at Internet success.

During the thick of the dot-com mania 20 years ago, Loew and some friends built an online publishing company called Worldweb.net. It had 150 employees and $15 million in revenue but, like many start-ups from the era, it never posted a profit.

EY today announced the finalists for the Entrepreneur Of The Year 2017 Award in the Maryland Region. The awards program recognizes entrepreneurs who are excelling in areas such as innovation, financial performance and personal commitment to their businesses and communities. These business leaders were selected by a panel of independent judges. Award winners will be announced at a special gala on June 28, 2017 at the Baltimore Marriott Waterfront Hotel.

June 13, 2017 – 6:00pm – 9:00pm

Bethesda North Marriott Hotel and County Conference Center 5701 Marinelli Road, North Bethesda, MD 20852

Tuesday, June 13 MCCC 58th Annual Dinner honoring Dr. Martine Rothblatt and United Therapeutics as the Visionary of the Year United Therapeutics Corporation is a bio-tech company focused on the development and commercialization of innovative products to address the unmet medical needs of patients with chronic and life-threatening conditions. They have five approved products on the market today and are in relentless pursuit of “medicines for life”®. Their overarching commitment to environmental sustainability is reflected in their new corporate office facility in Silver Spring. This seven-story, 108,000-sq.-ft., cutting-edge collaborative workspace aims to inspire people think out of today’s box and into the realm of tomorrow.

Immigration advocates claim that about half of the most lucrative startups in America were founded by immigrants. But it’s complicated for a foreigner to start a company in America — there’s no such thing as a startup visa.

That’s why some entrepreneurs are “hacking the system” through a workaround that started as an experiment in Massachusetts and has expanded to five other states.

VentureApp, a professional chat platform, today announced VentureMap New York City, an interactive network visualization of the city’s tech ecosystem, in partnership with RRE Ventures. The map displays 3,043 investments into tech startups by angel investors, venture capitalists, incubators, accelerators, and more.

Sitting around a table before class, Shane Yeager talked about one of his two startups.

“Short Clips is a technology service where brands and agencies can take their media files — videos, audio, photos — put them into our platform, and then within 24 hours, get a professionally cut 15-second to one-minute video,” he said.

QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced the formation of a joint venture with Maccura Biotechnology Co., Ltd., a leading in vitro diagnostics (IVD) company in China. The joint venture, named MAQGEN plans to accelerate local adaptations, development and commercialization of the GeneReader NGS System in the rapidly growing clinical and clinical research markets in China. QIAGEN’s GeneReader NGS System is the world’s first complete Sample to Insight solution and makes the benefits of next-generation sequencing (NGS) accessible to any laboratory.

Pieris today announced a strategic collaboration in respiratory diseases with AstraZeneca to develop novel inhaled drugs that leverage Pieris’ Anticalin® platform, including its lead preclinical drug candidate, PRS-060.

Anticalin molecules are engineered proteins which can mimic antibodies by binding to sites either on other proteins or on small molecules. They are smaller than monoclonal antibodies, offering the potential of direct delivery to the lung.